Richard F. Pops
Independent DirectorMr. Richard F. Pops is Chairman of Alkermes PLC since September 16, 2011 and serves as its Director September 2011. He was the Chief Executive Officer of Alkermes PLC since September 2011 until July 31, 2026. Mr. Pops was the Founder of Genomics Collaborative, Inc. He was a Co-founder of Sirtris Pharmaceuticals, Inc. He served as Chief Executive Officer of Alkermes, Inc. from September 2009 to September 2011 and previously served as its Chief Executive Officer from February 1991 to April 2007 since joining in 1991. He served as the President of Alkermes, Inc. from September 11, 2009 to September 16, 2011. He was employed by PaineWebber Development Corporation as a Vice President. He served as Chairman of Alkermes, Inc. from April 01, 2007 to September 2011 and served as its Director from February 1991 to September 2011. He had been a Director at Acceleron Pharma, Inc. since June 2004 until December 31, 2019. Mr. Pops has been an Independent Director of Neurocrine Biosciences Inc. since April 16, 1998. He has been Member of Value and Coverage Advisory Council at FasterCures/The Center for Accelerating Medical Solutions since January 2015. He serves a Director at New England Healthcare Institute (NEHI). He serves as a Director At Large at Biotechnology Innovation Organization. He served as a Member of Advisory Board at Polaris Venture Partners. Mr. Pops serves as a Trustee of Fessenden School, The. He serves on board of The Biotechnology Industry Organization (BIO); the Pharmaceutical Research and Manufacturers of America (PhRMA) and the National Health Council. He served as a Lead Director at Acceleron Pharma, Inc. since October 2007. He served as a Member of Harvard Medical School Board of Fellows from 2002 to June 2012. He served as a Member of Advisory Board at Polaris Venture Partners, Inc. He served as Director of Sirtris Pharmaceuticals, Inc from 2004 to 2008 and CombinatoRx, Inc. from 2001 to 2009. He served as a Director of Expressive Constructs, Inc. He served as Director of Genomics Collaborative, Inc. He served as an Independent Director of Epizyme, Inc. from September 2008 to October 2020. He served as a Director of Zalicus Inc. from October 2001 to December 2009 and Reliant Pharmaceuticals, Inc. since June 2006. He served as a Director at The Massachusetts Biotechnology Council. He served as Chair for the Harvard Medical School Advisory Council for Biological Chemistry & Molecular Pharmacology (BCMP). Mr. Pops received a B.A. in Economics from Stanford University in 1983.
Positions
- Company NameNeurocrine Biosciences, Inc.Stock CodeNBIXPositionIndependent DirectorColleagues
- KWKyle W. GanoPresident, CEO & Director
- WHWilliam H. RastetterIndependent Chairman of the Board
- MCMatthew C. AbernethyChief Financial Officer
- JOJude OnyiaChief Scientific Officer
- ESEric S. BenevichChief Commercial Officer
- EWEiry Wyn RobertsChief Medical Officer
- RFRichard F. PopsIndependent Director
- LVLeslie V. NorwalkIndependent Director
- SSShalini SharpIndependent Director
- Company NameAlkermes plcStock CodeALKSPositionChairmanColleagues
- BCBlair C. JacksonPresident, CEO & Director
- JRJoshua ReedSenior VP & CFO
- DJDavid Joseph GaffinExecutive VP, Chief Legal Officer, Chief Compliance Officer & Secretary
- CCCraig C. HopkinsonExecutive VP of Research & Development and Chief Medical Officer
- CTChristian Todd NicholsSenior VP & Chief Commercial Officer
- SMShane Martin CookeIndependent Director
- RBRichard Brian GaynorIndependent Director
- BPBrian P. McKeonIndependent Director
